Cargando…

Efficacy of intravenous eptifibatide in primary percutaneous coronary intervention patients

Early and complete restoration of blood flow in closed coronary arteries is the main goal in treating patients with myocardial infarction. Primary angioplasty is not always successful in establishing myocardial blood flow. Although the strategy of adding eptifibatide leads to better blood flow, its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jalalian, Rozita, Golshani, Samad, Farsavian, Hossein, Vatani, Mahsa, Farsavian, Ali Asghar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Carol Davila University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321601/ https://www.ncbi.nlm.nih.gov/pubmed/34377204 http://dx.doi.org/10.25122/jml-2021-0035

Ejemplares similares

Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin
por: Golshani, Samad, et al.
Publicado: (2022)

Impact of maintenance dose of eptifibatide in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
por: Jalalian, Rozita, et al.
Publicado: (2023)

Transient lateral rectus palsy associated with acute coronary syndrome treated with percutaneous coronary intervention: a case report
por: Farsavian, Ali Asghar, et al.
Publicado: (2023)

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention
por: Doustkami, Hossein, et al.
Publicado: (2018)

Comparing efficacy of receiving different dosages of eptifibatide in bleeding after percutaneous coronary intervention in patients with myocardial infarction
por: Shemirani, Hasan, et al.
Publicado: (2019)

Comparison between Intracoronary Abciximab and Intravenous Eptifibatide Administration during Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction
por: Namazi, Mohammad Hasan, et al.
Publicado: (2013)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
por: Marian, Moazez J., et al.
Publicado: (2017)

Clinical and economic studies of eptifibatide in coronary stenting
por: Pasala, Tilak, et al.
Publicado: (2014)

Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial
por: Elbadawi, Ayman, et al.
Publicado: (2016)

Pseudoaneurysm of the Posterior Tibial Artery following Removal of Tibial Plate- A Rare Case
por: Ghaffari, Salman, et al.
Publicado: (2016)

Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Publicado: (2014)

Profound thrombocytopenia after primary exposure to eptifibatide
por: Norgard, Nicholas B, et al.
Publicado: (2010)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes
por: Shah, Ibrahim, et al.
Publicado: (2010)

Extraskeletal Mesenchymal Chondrosarcoma of Shoulder: An Extremely Rare Case
por: Ghaffari, Salman, et al.
Publicado: (2016)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]
Publicado: (2014)

Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial
por: Marian, Moazez J., et al.
Publicado: (2019)

The estimate of average age at the onset of acute myocardial infarction in Iran: A systematic review and meta-analysis study
por: Sharif Nia, Hamid, et al.
Publicado: (2018)

Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients
por: Rathod, KS, et al.
Publicado: (2017)

The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction; A randomized clinical trial study
por: Ghazal, Abdullatef, et al.
Publicado: (2019)

A rare case of eptifibatide-induced thrombocytopenia
por: Kamar, Khalil, et al.
Publicado: (2021)

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia
por: Byrne, John, et al.
Publicado: (2015)

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation
por: Shariati, Hooman, et al.
Publicado: (2016)

Acute Severe Thrombocytopenia Occurring After Administration of Eptifibatide Postpones Emergent Coronary Artery Surgery
por: Boettcher, Brent T., et al.
Publicado: (2016)

Eptifibatide and Cirrhosis: Rethinking GPIIb-IIIa Inhibitors for Acute Coronary Syndrome in the Setting of Liver Dysfunction
por: Weinreich, Michael, et al.
Publicado: (2014)

How Safe is Eptifibatide during Urgent Carotid Artery Stenting?
por: Allam, Hesham, et al.
Publicado: (2013)

Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014)

Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
por: Aljundi, Amer, et al.
Publicado: (2020)

Eptifibatide-induced acute profound thrombocytopenia: A case report
por: Alamin, Mohammed A., et al.
Publicado: (2022)

Remote ischemic preconditioning to reduce contrast-induced acute kidney injury in chronic kidney disease: a randomized controlled trial
por: Ghaemian, Ali, et al.
Publicado: (2018)

Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction (PENTOS-PCI)
por: Kakavand, Hessam, et al.
Publicado: (2023)

Comparing the Therapeutic Effects of Carvedilol and Metoprolol on Prevention of Atrial Fibrillation after Coronary Artery Bypass Surgery, a Double-Blind Study
por: Jalalian, Rozita, et al.
Publicado: (2014)

The Effect of Acupressure on Preventing Constipation in Patients with Acute Myocardial Infarction under Primary Percutaneous Coronary Intervention
por: Kamali, Mahsa, et al.
Publicado: (2022)

Acute Profound Thrombocytopenia Induced by Eptifibatide Causing Diffuse Alveolar Hemorrhage
por: Byrd, Gregory, et al.
Publicado: (2021)

The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells
por: Hajtuch, Justyna, et al.
Publicado: (2022)

The Role of Doppler Imaging in the Assessment of Right Ventricular Function: a Case-control Study of Acute Inferior Wall Infarction
por: Dabirian, Mojdeh, et al.
Publicado: (2018)

Cardiac CT in Detecting a Dislodged Stent in Right Coronary Artery after Primary Percutaneous Coronary Intervention
por: Ashraf, Tariq, et al.
Publicado: (2019)

QT Dispersion: Does It Change after Percutaneous Coronary Intervention?
por: Alasti, Mohammad, et al.
Publicado: (2011)

Comparison of myocardial reperfusion between intracoronary versus intravenous cangrelor administration in patients undergoing primary percutaneous coronary intervention
por: Muraca, Iacopo, et al.
Publicado: (2023)

The relationship between Aldosterone level and various LV conditions in patients with End-stage renal disease
por: Nesarhosseini, Vida, et al.
Publicado: (2019)

Primary percutaneous coronary intervention in nonagenarians: is it worthwhile?
por: Meah, Mohammed M. N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ruqbp8b0v7euos9qrl74fquf3o